#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral arteriovenous malformation haemorrhagic Myelofibrosis Loeys-Dietz syndrome Atypical haemolytic uraemic syndrome Gaucher's disease type I Osteosarcoma Mucopolysaccharidosis III Retinal artery occlusion Methylmalonic acidaemia Haemophilia Waldenstrom's macroglobulinaemia refractory Myelodysplastic syndrome with excess blasts Pulmonary alveolar haemorrhage Cervix carcinoma Neonatal alloimmune thrombocytopenia More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome Gastrointestinal stromal tumour – Trials in Disease Breast angiosarcoma – Diagnostics Toxic epidermal necrolysis – Trials in Disease Angiosarcoma metastatic – Diagnostics Angiosarcoma non-metastatic – Treatment Primary mediastinal large B-cell lymphoma – Trials in Disease Cystic fibrosis – Trials in Disease Chronic granulomatous disease – Trials in Disease MELAS syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tetracosactide 18F-Psma-1007 Munc-Cd34 Sodium Iodide (123 I) Hyoscine Vinorelbine Roxithromycin DAPIGLUTIDE Benfotiamine Aspartic Acid Esmolol Hydrochloride Suxamethonium Chloride ZUNIBERGENE ROCPARVOVEC Cloxacillin Sodium Rbl005.3 Transcon Il-2Β/Γ Lisocabtagene Maraleucel Pbf-999 Furosemide Timolol Maleate More therapies…

    Learn about Your Condition

    Urinary tract infection Cytokine release syndrome Rectosigmoid cancer Ovarian cancer recurrent Plasma cell myeloma Mitochondrial myopathy Double hit lymphoma Neck pain Critical illness Polycystic ovarian syndrome Cardiac failure acute Penile squamous cell carcinoma Chorioretinitis Pleomorphic liposarcoma Breast neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny W Bialymstoku

Uniwersytecki Szpital Kliniczny W Bialymstoku

Zurawia 14, Bialystok, 15-540, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Dried Ferrous Sulfate
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland

  • Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Germany Hungary Poland Romania Slovakia Spain

  • A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

    Recruiting

    3 1
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nemolizumab
    Bulgaria Croatia France Greece Italy Poland +1

  • Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Topotecan Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Pembrolizumab
    • Resiquimod Sulfate
    Austria Belgium Bulgaria France Germany Greece +6

  • Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Ovarian cancer
    • Ovarian cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark France Germany +9

  • Long-Term Study of Imeroprubart in Adults With Graves’ Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Graves’ disease
    Investigated Drugs:
    • IMEROPRUBART
    Belgium Bulgaria Czechia Germany Greece Hungary +5

  • Phase 3 Study of INCB123667 versus investigator’s choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    • Paclitaxel
    Belgium France Germany Ireland Italy The Netherlands +2

  • Comparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Calcium Folinate
    • Carboplatin
    Austria Belgium Bulgaria Czechia Denmark France +11
1 2 3 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!